ArticleJournal of pediatric gastroenterology and nutrition2026
Prior emergency department visits predict future emergency department use in pediatric inflammatory bowel disease.
Article in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesEmergency department (ED) visits represent a significant cost in the care of children with inflammatory bowel disease (IBD). Many of these visits are potentially preventable. We aimed to evaluate factors associated with ED use in pediatric patients with IBD.
methodsPatients with IBD aged 0-21 years at a single tertiary center were identified via electronic medical record query. Demographics, disease characteristics, and recent laboratory results were extracted. ED visits in the 6 months following data extraction were tallied. Multivariable logistic regression was performed to evaluate risk factors for ED use. Kaplan-Meier curve analysis was used to understand the risk of IBD-related ED use over time following initial diagnosis.
resultsOf the 531 patients identified, 49 (9%) visited the ED during the study period and 22 (4.1%) had an IBD-related visit. Number of recent ED visits (odds ratio [OR] 3.168, 95% confidence interval [CI] 1.925-5.466), public insurance (OR 2.232, 95% CI 1.021-4.665), and IBD diagnosis within the last 6 months (OR 2.964, 95% CI 1.039-7.918) were risk factors for all-cause ED use, though only number of recent ED visits (OR 2.105, 95% CI 1.110-3.668) was associated with IBD-related ED use. For the 391 patients included in the analysis of IBD-related ED use over time, the rate of ED use was highest the first month after diagnosis (slope 0.268, 95% CI 0.258-0.279) and plateaued over the following year.
conclusionsRecent ED use, regardless of cause, is an important risk factor for IBD-related ED use in pediatric patients. The first several months after diagnosis constitute a particularly high-risk time for ED use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.